The Naver-owned messaging service, which initially planned to float last year, has suspended its plans to go public again.

The cancer treatment developer has raised $94m in equity and grant funding, with Pfizer, Celgene and Baxter among its shareholders.

The cancer treatment developer has raised $94m in equity and grant funding, with Pfizer, Celgene and Baxter among its shareholders.

General electric-backed genomics tool developer RainDance Technologies has called off its initial public offering after raising more than $100m in equity.

Gene therapy developer RegenXBio, backed by investors including GlaxoSmithKline, has so far raised more than $110m in venture funding.

The Delta Electronics-backed company, which has developed an artificial heart for transplants, has filed for a $40m initial public offering on Nasdaq.

The ProSiebenSat.1 and Access Industries-backed music streaming service is considering another equity round or an initial public offering to raise more cash.

The Samsung-backed flash storage company was valued at $3bn as of its last funding round, a $225m series F round closed last year.

Biotechnology company FortuneRock is set to float on the National Equities Exchange and Quotations in China, giving Jinhua Pharmaceuticals an exit.

The Rocket Internet and Vorwerk-backed meal delivery service would likely be valued at about $1.1bn in the offering, after raising almost $200m in funding.